|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the EYE 8-K filed Apr 25, 2007. Eye Care Manufacturing Update During the quarter, production resumed as planned on three of the four manufacturing lines at the company’s China facility, which supplies primarily the Japanese and Asia Pacific markets. Eye care product shipments also resumed to these markets during the first quarter. The company expects to experience some supply shortages in Asia Pacific and Japan through the second quarter of 2007, as supply ramps up to meet demand. The plant’s fourth line is scheduled to begin production in the next 30 to 45 days, consistent with the company’s original schedule. Production at the company’s eye care manufacturing facility in Spain, which supplies North American and European markets, continued uninterrupted during this time. The U.S. Food and Drug Administration (FDA) plans to conduct routine inspections of AMO’s eye care manufacturing facilities in Spain and China during May and June 2007. AMO had indicated previously that such inspections were expected. The company is cooperating fully with the FDA and does not anticipate any impact to production as a result of the inspections. |
| |||||||
